![CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040235700/2053766526/gr1.jpg)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology
PLOS ONE: PTEN as a Prognostic and Predictive Marker in Postoperative Radiotherapy for Squamous Cell Cancer of the Head and Neck
![Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press](https://images.nap.edu/books/12146/gif/52.gif)
Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press
![Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO](https://www.esmo.org/var/esmo/storage/images/esmo/esmo-staff/impakt-prep/impakt-2015-news/abstract-39o-impakt-2015/1137949-1-eng-GB/Abstract-39O-IMPAKT-2015_i1200.jpg)
Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer | ESMO
![Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936523316300821-gr1.jpg)
Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer - ScienceDirect
![Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12d0e658-a40b-400e-996f-87549adc4f14/gr1.jpg)
Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease - Respiratory Medicine
![Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031302520310060-gr1.jpg)
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
![PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dbd4fbdf-ffaa-4636-b28c-91ec672c29f4/gr1_lrg.jpg)
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis - European Journal of Obstetrics and Gynecology and Reproductive Biology
PLOS ONE: The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
![PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657 PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657](https://image3.slideserve.com/5807657/slide1-l.jpg)
PPT - Table 2 Studies of the VEGF pathway as a predictive marker in breast cancer PowerPoint Presentation - ID:5807657
![Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society](https://erj.ersjournals.com/content/erj/56/suppl_64/4493/F1.large.jpg)
Utility of pleural fluid for predictive marker testing in malignant pleural effusion | European Respiratory Society
![Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press](https://images.nap.edu/books/12146/gif/53.gif)
Screening for Predictive Markers | Improving the Quality of Cancer Clinical Trials: Workshop Summary | The National Academies Press
![The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma - Lung Cancer The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/76c26632-4fc3-4fe1-9084-31088b81b54b/gr1.jpg)
The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma - Lung Cancer
![Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bec8d922-387f-45c5-8689-b81767fac1ec/gr1.jpg)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - Annals of Oncology
![Molecular Staging of Colorectal Carcinoma: The EGF 61 A/G polymorphism ? a predictive marker for recurrence of liver metastases from colorectal cancer: Kovar MD, Florian M, Poyntner MD, Lukas, Endler MD univ.Doz., Molecular Staging of Colorectal Carcinoma: The EGF 61 A/G polymorphism ? a predictive marker for recurrence of liver metastases from colorectal cancer: Kovar MD, Florian M, Poyntner MD, Lukas, Endler MD univ.Doz.,](https://images-na.ssl-images-amazon.com/images/I/510pcvCScAL._SX339_BO1,204,203,200_.jpg)
Molecular Staging of Colorectal Carcinoma: The EGF 61 A/G polymorphism ? a predictive marker for recurrence of liver metastases from colorectal cancer: Kovar MD, Florian M, Poyntner MD, Lukas, Endler MD univ.Doz.,
![Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients. - Abstract - Europe PMC Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5967614/bin/nihms968151f1.jpg)